Fumou Sun

Assistant Professor

UAMS

18 h-index 67 pubs 860 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Fumou Sun's research program centers on investigating mechanisms of cancer, with a particular focus on multiple myeloma and hepatocellular carcinoma. Sun has published work exploring the role of FOXM1 in regulating glycolysis and energy production in multiple myeloma, as well as studies on bispecific antibody and CAR-T cell therapies targeting multiple myeloma and hepatocellular carcinoma. Additional research areas include the development of nanoparticle-based drug delivery systems for enhanced cancer therapy and the investigation of immune microenvironment alterations in multiple myeloma and its precursor stages. Sun's work also extends to exploring the protective effects of plant-derived compounds, such as Momordica charantia polysaccharides, against cerebral ischemia/reperfusion injury by inhibiting oxidative stress signaling pathways.

Metrics

h-index: 18
Publications: 67
Citations: 860

Positions

Assistant Professor 2024–present

Medical College of Wisconsin Department of Medicine ORCID
Assistant Professor

University of Arkansas for Medical Sciences ORCID

Selected Publications

Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma (2025)

Cancer Biomarkers 1 citation DOI OpenAlex
Cystatin M/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone Resorption (2025)

Cancers 1 citation DOI OpenAlex
Multi-Omics Reveal Immune Microenvironment Alterations in Multiple Myeloma and Its Precursor Stages (2024)

Blood 1 citation DOI OpenAlex
Of Seven Molecular Subtypes in MGUS the Low Bone Disease (LB) Subtype Exhibits Resistance to Multiple Myeloma Progression (2024)

Blood DOI OpenAlex
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages (2024)

Blood Cancer Journal 38 citations DOI OpenAlex
Cystatin M/E ameliorates bone resorption through increasing osteoclastic cell estrogen influx (2024)

Research Square 1 citation DOI OpenAlex
A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation (2024)

Cancers 4 citations DOI OpenAlex
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing (2024)

Blood Cancer Journal 7 citations DOI OpenAlex
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems (2024)

Blood Cancer Journal 7 citations DOI OpenAlex
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth (2024)

Nature Communications 47 citations DOI OpenAlex
A 5-Stage System for ASCT Multiple Myeloma (2023)

Blood DOI OpenAlex
Prognostic Value of Ferritin in ASCT MM Patients: Integration with GEP Models and ISS Series Systems (2023)

Blood 1 citation DOI OpenAlex
BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions (2023)

Journal of Clinical Investigation 7 citations DOI OpenAlex
High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma (2023)

Cell Reports Medicine 17 citations DOI OpenAlex
P-066 BCMA-CAR-T cells with synthetic circuits of CST6 lyse tumor cells and suppress osteolytic lesions in multiple myeloma (2023)

Clinical Lymphoma Myeloma & Leukemia DOI OpenAlex